A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma

NCT00675649 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: CNTO 148 / Golimumab
BIOLOGICAL: placebo

Sponsor

Centocor, Inc.